EFLUELDA
INJ SUS ISP 5X0,7ML
SÚKL code | 0239063 |
---|---|
Name of the product | EFLUELDA |
_MA_MEDICATION_DETAIL_INFO_MED_NAME i | EFLUELDA |
Supplement | INJ SUS ISP 5X0,7ML |
Strenght | |
Pharmaceutical form | Suspension for injection in pre-filled syringe |
Package | 5X0,7ML |
Route | Subcutaneous/intramucsular use |
Language of the pack | Czech |
Wrap type | Pre-filled syringe |
Legal status | na lékařský předpis |
Active substance |
INFLUENZA VIRUS B/PHUKET (INFLUENZAE VIRUS B/PHUKET) INFLUENZA VIRUS A/VICTORIA (H1N1) (INFLUENZAE VIRUS A/VICTORIA (H1N1)) INFLUENZA VIRUS A/CAMBODIA (H3N2) (INFLUENZAE VIRUS A/CAMBODIA (H3N2)) INFLUENZA VIRUS B/WASHINGTON (INFLUENZAE VIRUS B/WASHINGTON) |
ATC group | J07BB02 |
ATC group name | CHŘIPKA, INAKTIVOVANÁ VAKCÍNA, ŠTĚPENÝ VIRUS NEBO POVRCHOVÝ ANTIGEN |
Marketing authorisation information
Registration Number | 59/ 173/19-C |
---|---|
Type of MA | A mutual recognition procedure (MRP, DCP), where CZ is Concerned member state |
MA status | R - active MA/authorised medicinal product |
MA Holder | Sanofi Pasteur, Lyon |
MA Holder country | FRANCIE |